Clinical Trials at the Summit brings together a diverse group of experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of accelerating advances in vitreoretinal care.
External link for CTS Retina
CTS Retina reposted this
A phase 3 program will investigate bel-sar delivered through a suprachoroidal injection and activated with a laser in patients with #choroidalmelanoma. J. Jill Hopkins, MD, of Aura Biosciences discusses the program 👇 #OcularSurgeryNews #CTSRetina CTS Retina https://lnkd.in/e7z5AwdX
CTS Retina reposted this
CTS Retina coverage continues! In the The SUMMIT study, the port delivery system showed a real-world maintenance of #visualacuity and central subfield thickness, as well as a well-tolerated safety profile, in patients with neovascular #AMD. Arshad M. Khanani, MD, MA, FASRS, discussed the details with Healio 👇 #OcularSurgeryNews #Retina Genentech https://lnkd.in/ePyMfG42
It’s been an exciting week for our colleagues at Genentech - after two years, #Susvimo makes a comeback! Carlos Quezada Ruiz provided this update at the #CTS2024 meeting.
❗ NEW ❗ #Susvimo has reportedly shown positive data across three different phase 3 trials in #DR, #DME and neovascular #AMD. Carlos Quezada Ruiz, MD, FASRS, discussed these results at #CTSRetina 👇 #OcularSurgeryNews Genentech CTS Retina https://lnkd.in/eTh-Em26
CTS Retina reposted this
🚨ICYMI🚨 Charles Semba (仙波), MD, of Eluminex Biosciences Limited, discussed EB-105, trispecific antibody for #DME that targets VEGF-A, VEGF-B, placental growth factor, angiopoietin-2 and interleukin-6 receptor, at #CTS_Retina. “We hope the combination of these three [moieties] will present an incremental breakthrough to really address the difficult nature in treating residual fluid in patients with #diabeticeyedisease,” he said. Full Healio 📽 below. #OcularSurgeryNews CTS Retina #Ophthalmology #Retina https://lnkd.in/e9HiYQa9
CTS Retina reposted this
Ixo-vec has shown promise in reducing the number of #aflibercept injections in neovascular #AMD. Adam Turpcu, PhD, of Adverum Biotechnologies discussed the #genetherapy with Healio at CTS Retina. 🔗 #OcularSurgeryNews #Retina https://lnkd.in/eeBdQpKG
CTS Retina reposted this
Ramanath Bhandari, MD, FASRS, of RevOpsis Therapeutics discusses the development of RO-104 for the treatment of retinal disease. 🔗 below #OcularSurgeryNews #Retina #CTS_Retina CTS Retina https://lnkd.in/ecHWeJTp
CTS Retina reposted this
A phase 3 trial of elamipretid for #dryAMD is targeting the new #FDA-approved endpoint of photoreceptor protection. Reenie McCarthy of Stealth BioTherapeutics spoke with Healio about the details 🔗 #ocularSurgeryNews #CTS_Retina CTS Retina https://lnkd.in/eX5G5VKn
CTS Retina reposted this
4D-150 demonstrated positive safety, retinal anatomy and durability results, as well as a reduction in the need for annualized anti-VEGF injections in patients with wet #AMD, in the PRISM phase 2 clinical trial. The company has also filed an investigational new drug application for 4D-175 for the treatment of #geographicatrophy. David Kirn, MD, of 4D Molecular Therapeutics spoke with Healio at CTS Retina 🔗 #OcularSurgeryNews #ophthalmology #CTSRetina #Retina https://lnkd.in/ehKwBDpq
CTS Retina reposted this
In the CALM study, Yutiq for chronic noninfectious uveitis demonstrated: 👉 A reduction in #uveitis flares. 👉 Improved OCT. 👉 Positive #IOP profile. Michael Singer, MD, shares the details from #CTS_Retina. #OcularSurgeryNews Alimera Sciences Ophthalmologie GmbH CTS Retina https://lnkd.in/ePR4Fr8A
CTS Retina reposted this
#CTS_Retina coverage continues! Kodiak Sciences Inc. is preparing to enter ❗three❗ of its retinal therapies into phase 3 clinical trials "this year." CEO Victor Perlroth, MD, spoke with Healio about the details 🔗 #OcularSurgeryNews #Retina CTS Retina https://lnkd.in/eHEANwV6